Point:Counterpoint: Hypoxic pulmonary vasoconstriction is/is not mediated by increased production of reactive oxygen species

Abstract

POINT-COUNTERPOINTPoint:Counterpoint: Hypoxic pulmonary vasoconstriction is/is not mediated by increased production of reactive oxygen speciesJeremy P. T. WardJeremy P. T. WardPublished Online:01 Sep 2006https://doi.org/10.1152/japplphysiol.00480.2006This is the final version - click for previous versionMoreSectionsPDF (159 KB)Download PDF ToolsExport citationAdd to favoritesGet permissionsTrack citations ShareShare onFacebookTwitterLinkedInEmailWeChat PURPOSE AND SCOPE OF THE POINT:COUNTERPOINT DEBATES This series of debates was initiated for the Journal of Applied Physiology because we believe an important means of searching for truth is through debate where contradictory viewpoints are put forward. This dialectic process whereby a thesis is advanced, then opposed by an antithesis, with a synthesis subsequently arrived at, is a powerful and often entertaining method for gaining knowledge and for understanding the source of a controversy. Before reading these Point:Counterpoint manuscripts or preparing a brief commentary on their content, the reader should understand that authors on each side of the debate are expected to advance a polarized viewpoint and to select the most convincing data to support their position. This approach differs markedly from the review article where the reader expects the author to present balanced coverage of the topic. Each of the authors has been strictly limited in the lengths of both the manuscript (1,200 words) and the rebuttal (400). The number of references to publications is also limited to 30, and citation of unpublished findings is prohibited. POINT: HYPOXIC PULMONARY VASOCONSTRICTION IS MEDIATED BY INCREASED PRODUCTION OF REACTIVE OXYGEN SPECIESHypoxic pulmonary vasoconstriction (HPV) diverts blood away from poorly ventilated regions of the lung and so optimizes gas exchange. Great strides have been made in recent years in the search for the mechanisms of HPV, although not necessarily in the same direction. Although there is agreement that these mechanisms reside within the pulmonary artery (PA) and include elevation of smooth muscle intracellular [Ca2+] ([Ca2+]i) and increased Ca2+ sensitivity (4, 16, 21, 24), the identity of the transduction pathways is somewhat controversial—discussions concerning the oxygen sensor and its distal signaling moieties often end in wailing and gnashing of teeth. The most significant disagreement concerns the role of reactive oxygen species (ROS) and whether an increase (e.g., Ref. 24) or decrease (e.g., Refs. 14, 29) in ROS production acts as the initiating stimulus for HPV. And let us not forget the “Who cares?” constituency, who oppose any role for ROS in HPV whatsoever (e.g., Refs. 4, 6). We believe the evidence is strongly in favor of the first option and have no qualms about going mano e mano with our friends in the North.Most agree that mitochondria function as the oxygen sensor for HPV (but see Ref. 29). Oxidation of NADH by complex I of the electron transport chain (ETC), and FADH2 and succinate by complex II, results in transfer of electrons by ubiquinol to complex III, and thence via cytochrome c to cytochrome oxidase (COX; complex IV), where O2 is the final electron acceptor. Proton extrusion in complexes I, III, and IV generates the mitochondrial membrane potential (ΔΨm) that drives ATP synthesis. If Po2 falls sufficiently, electron transport slows, ΔΨm depolarizes, and ATP production may decrease. Curmudgeonly biochemists have questioned whether this occurs in “physiological” hypoxia (20–50 mmHg Po2) as the affinity of COX for O2 is ∼0.5 mmHg Po2; it is patently clear, however, that it does in intact cells and tissues (e.g., Refs. 2, 10, 13). About 3% of electron flux is constitutively lost throughout the ETC by univalent donation of electrons to O2 to form superoxide, primarily at complexes I and III; ubisemiquinone is the donor in complex III, but only when formed at the Qo site can superoxide enter the mitochondrial intermembrane space (Fig. 1; Refs. 18, 19). Superoxide is converted by superoxide dismutase (SOD) to H2O2, the ROS signaling moiety of choice. A simplistic view would predict that because O2 is the substrate for ROS production, then clearly as [O2] falls so should ROS. However, the rate of ROS formation is proportional to [O2] × [electron donor], the latter being increased if electron transport is slowed and the proximal ETC becomes more reduced (18). Thus ROS production would increase if [electron donor] (e.g., ubisemiquinone) increases more than [O2] falls—antimycin A, which inhibits cyt bH and increases ubisemiquinone lifetime, promotes ROS generation (19). The above relationship could explain the apparent paradox that both hypoxia and hyperoxia (5) increase ROS; in normoxia, [O2] is maximal for COX, so hyperoxia could not affect electron transport or [electron donor].Fig. 1.Simplified, easy to understand summary diagram of the mitochondrial electron transport chain, sites of reactive oxygen species (ROS) production, and key sites of experimental intervention. Some elements are omitted for clarity. Note that ROS entering the matrix are probably largely recycled via cytochrome c or degraded by the powerful antioxidant environment. C, cytochrome c; CuZnSod,: Cu-Zn superoxide dismutase; F1F0, ATP synthetase; FeS, Rieske Fe-S center; GPX, glutathione peroxidase; SO·, superoxide radical; Q, ubiquinone; QH2, ubiquinol; QH·, ubisemiquinone; Qo/Qi, external and internal sites of complex III.Download figureDownload PowerPointSo if ROS production can increase in hypoxia, does it, in fact, do so? Here those unlucky readers not in the field ask “Why not just measure it and leave us in peace?” Therein lies the rub. It has been, and we are not at peace. Various indicators, including dichlorofluorescein (DCF), have been used to show increased ROS production in live cells during hypoxia, often suppressed as predicted by antioxidants and/or catalase (9, 11, 12, 22, 23). However, many believe that DCF is an unreliable witness that should be consigned to the dustbin of history. But luminol and lucigenin also have shortcomings and, especially in complex preparations such as perfused lungs, are likely to detect primarily extracellular ROS. These are largely derived from NAD(P)H oxidases and may well fall in hypoxia (29), effectively obfuscating concomitant increases in cytosolic ROS. Notably, the Schumacker group (7) has demonstrated an increase in ROS during hypoxia using a novel fluorescence resonance energy transfer-based intracellular sensor, with fewer shortcomings. Importantly, hypoxic signaling is associated with DNA base oxidation products in PA endothelial and smooth muscle cells (SMC) (30), strongly implying an increase in cytosolic oxidant stress.If HPV is mediated by an increase in ROS then we can make certain predictions. At the most basic level, antioxidants should suppress HPV without mimicking hypoxia, whereas exogenous ROS should do the opposite. A significant body of evidence supports this prediction. For example, superoxide scavengers (26, 27), SOD inhibitors (which prevent breakdown to H2O2) (22, 28), catalase (which breaks down H2O2) (11, 17, 23), and agents that enhance or mimic the glutathione antioxidant axis (22, 23) all suppress HPV and/or the associated elevation in [Ca2+]i without mimicking hypoxia. Rather more damning for the opposition are reports that exogenous H2O2 causes PA vasoconstriction in normoxia (8, 22), and we have recently shown that low concentrations (1–100 μM) of H2O2 or menadione (a promoter of intracellular ROS generation) cause sustained constrictions and elevations of [Ca2+]i in intrapulmonary arteries (IPA) with similarities to those induced by hypoxia (3). Conversely the same concentrations of H2O2 generally vasodilate systemic arteries (e.g., Refs. 3, 15). High concentrations of ROS may constrict or relax PA (8), presumably in part by frying the preparation. At the very least, these studies would seem to predicate against the hypothesis that HPV is due to a fall in ROS.Indirect studies are also convincing. All agree that ETC inhibitors acting proximally to ubisemiquinone in complex III (e.g., rotenone: complex I; myxothiazol: complex III Rieske Fe-S center), caused distal oxidation, reduced availability of ubisemiquinone, and decreased ROS production. Thus if a rise in ROS does underlie HPV, proximal inhibition of the ETC should suppress HPV without mimicking hypoxia. Consistent with this, we and others have reported that proximal inhibitors not only suppress HPV without significantly affecting other vasoconstrictor mechanisms, but also do not elicit constriction or elevations in [Ca2+]i in normoxia (10, 22, 25); this is critical, because if a fall in ROS mediates HPV, then proximal inhibition should always mimic hypoxia. In addition, we have shown that the complex II substrate succinate, which bypasses complex I by providing electrons to complex III, restores HPV in the presence of rotenone (but not myxothiazol) (10, 21). As succinate restores electron transport in the presence of rotenone and thus ROS production at complex III, even with the wildest stretch of imagination it is extremely difficult to see how these data could be compatible with a decreased production of ROS being the stimulus for HPV; au contraire, they are entirely consistent with an increase.Finally, inhibition of COX (cyanide) and complex III distal to ubisemiquinone (antimycin A) might be expected to mimic hypoxia, by decreasing electron flux and increasing [ubisemiquinone], respectively. Indeed, cyanide has been shown to increase ROS, induce constriction in normoxia and/or enhance HPV (1, 10, 20, 22, 23), and antimycin A shows similar responses (1, 23).Doubtless our honorable opponents will try to convince you otherwise, perhaps using a different “spin” for interpretation of the above data, but we believe that even in this limited space we have provided sufficient evidence (summarized in the figure) for an almost insurmountable case for the defense, and that you the jury will now shout “Yes! HPV is indeed mediated by increased production of ROS (probably).”GRANTSOur work was supported by the Wellcome Trust and British Heart Foundation.Thanks are due for helpful comments (and otherwise) from other interested parties.REFERENCES1 Archer SL, Huang J, Henry T, Peterson D and Weir EK. A redox-based O2 sensor in rat pulmonary vasculature. Circ Res 73: 1100–1112, 1993.Crossref | PubMed | ISI | Google Scholar2 Chandel NS and Schumacker PT. Cellular oxygen sensing by mitochondria: old questions, new insight. J Appl Physiol 88: 1880–1889, 2000.Link | ISI | Google Scholar3 Esmaeil Pourmahram G, Becker S, Aaronson PI, and Ward JP. Low concentrations of reactive oxygen species cause vasoconstriction of small distal pulmonary arteries (Abstract). FASEB J 20: A1229, 2006.Google Scholar4 Evans AM, Mustard KJ, Wyatt CN, Peers C, Dipp M, Kumar P, Kinnear NP, and Hardie DG. Does AMP-activated protein kinase couple inhibition of mitochondrial oxidative phosphorylation by hypoxia to calcium signaling in O2-sensing cells? J Biol Chem 280: 41504–41511, 2005.Crossref | PubMed | ISI | Google Scholar5 Freeman BA and Crapo JD. Hyperoxia increases oxygen radical production in rat lungs and lung mitochondria. J Biol Chem 256: 10986–10992, 1981.Crossref | PubMed | ISI | Google Scholar6 Gonzalez C, Sanz-Alfayate G, Agapito MT, Gomez-Nino A, Rocher A, and Obeso A. Significance of ROS in oxygen sensing in cell systems with sensitivity to physiological hypoxia. Respir Physiol Neurobiol 132: 17–41, 2002.Crossref | PubMed | ISI | Google Scholar7 Guzy RD, Hoyos B, Robin E, Chen H, Liu L, Mansfield KD, Simon MC, Hammerling U, and Schumacker PT. Mitochondrial complex III is required for hypoxia-induced ROS production and cellular oxygen sensing. Cell Metab 1: 401–408, 2005.Crossref | PubMed | ISI | Google Scholar8 Jones RD and Morice AH. Hydrogen peroxide—an intracellular signal in the pulmonary circulation: involvement in hypoxic pulmonary vasoconstriction. Pharmacol Ther 88: 153–161, 2000.Crossref | PubMed | ISI | Google Scholar9 Killilea DW, Hester R, Balczon R, Babal P, and Gillespie MN. Free radical production in hypoxic pulmonary artery smooth muscle cells. Am J Physiol Lung Cell Mol Physiol 279: L408–L412, 2000.Link | ISI | Google Scholar10 Leach RM, Hill HS, Snetkov VA, Robertson TP, and Ward JPT. Divergent roles of glycolysis and the mitochondrial electron transport chain in hypoxic pulmonary vasoconstriction of the rat: identity of the hypoxic sensor. J Physiol 536: 211–224, 2001.Crossref | PubMed | ISI | Google Scholar11 Liu JQ, Sham JS, Shimoda LA, Kuppusamy P, and Sylvester JT. Hypoxic constriction and reactive oxygen species in porcine distal pulmonary arteries. Am J Physiol Lung Cell Mol Physiol 285: L322–L333, 2003.Link | ISI | Google Scholar12 Marshall C, Mamary AJ, Verhoeven AJ, and Marshall BE. Pulmonary artery NADPH-oxidase is activated in hypoxic pulmonary vasoconstriction. Am J Resp Cell Mol Biol 15: 633–644, 1996.Crossref | PubMed | ISI | Google Scholar13 Michelakis ED, Hampl V, Nsair A, Wu X, Harry G, Haromy A, Gurtu R, and Archer SL. Diversity in mitochondrial function explains differences in vascular oxygen sensing. Circ Res 90: 1307–1315, 2002.Crossref | PubMed | ISI | Google Scholar14 Michelakis ED, Thebaud B, Weir EK, and Archer SL. Hypoxic pulmonary vasoconstriction: redox regulation of O2-sensitive K+ channels by a mitochondrial O2-sensor in resistance artery smooth muscle cells. J Mol Cell Cardiol 37: 1119–1136, 2004.PubMed | ISI | Google Scholar15 Miura H, Bosnjak JJ, Ning G, Saito T, Miura M, and Gutterman DD. Role for hydrogen peroxide in flow-induced dilation of human coronary arterioles. Circ Res 92: e31–e40, 2003.Crossref | PubMed | ISI | Google Scholar16 Moudgil R, Michelakis ED, and Archer SL. Hypoxic pulmonary vasoconstriction. J Appl Physiol 98: 390–403, 2005.Link | ISI | Google Scholar17 Sheehan DW, Farhi LE, and Russell JA. Prolonged lobar hypoxia in vivo enhances the responsivity of isolated pulmonary veins to hypoxia. Am Rev Resp Dis 145: 640–645, 1992.Crossref | PubMed | ISI | Google Scholar18 Turrens JF. Mitochondrial formation of reactive oxygen species. J Physiol 552: 335–344, 2003.Crossref | PubMed | ISI | Google Scholar19 Turrens JF, Alexandre A, and Lehninger AL. Ubisemiquinone is the electron donor for superoxide formation by complex III of heart mitochondria. Arch Biochem Biophys 237: 408–414, 1985.Crossref | PubMed | ISI | Google Scholar20 Wang YX, Zheng YM, Abdullaev I, and Kotlikoff MI. Metabolic inhibition with cyanide induces calcium release in pulmonary artery myocytes and Xenopus oocytes. Am J Physiol Cell Physiol 284: C378–C388, 2003.Link | ISI | Google Scholar21 Ward JP, Snetkov VA, and Aaronson PI. Calcium, mitochondria and oxygen sensing in the pulmonary circulation. Cell Calcium 36: 209–220, 2004.Crossref | PubMed | ISI | Google Scholar22 Waypa GB, Chandel N, and Schumacker PT. Model for hypoxic pulmonary vasoconstriction involving mitochondrial oxygen sensing. Circ Res 88: 1259–1266, 2001.Crossref | PubMed | ISI | Google Scholar23 Waypa GB, Marks JD, Mack MM, Boriboun C, Mungai PT, and Schumacker PT. Mitochondrial reactive oxygen species trigger calcium increases during hypoxia in pulmonary arterial myocytes. Circ Res 91: 719–726, 2002.Crossref | PubMed | ISI | Google Scholar24 Waypa GB and Schumacker PT. Hypoxic pulmonary vasoconstriction: redox events in oxygen sensing. J Appl Physiol 98: 404–414, 2005.Link | ISI | Google Scholar25 Weissmann N, Ebert N, Ahrens M, Ghofrani HA, Schermuly RT, Hanze J, Fink L, Rose F, Conzen J, Seeger W, and Grimminger F. Effects of mitochondrial inhibitors and uncouplers on hypoxic vasoconstriction in rabbit lungs. Am J Respir Cell Mol Biol 29: 721–732, 2003.Crossref | PubMed | ISI | Google Scholar26 Weissmann N, Grimminger F, Voswinckel R, Conzen J, and Seeger W. Nitro blue tetrazolium inhibits but does not mimic hypoxic vasoconstriction in isolated rabbit lungs. Am J Physiol Lung Cell Mol Physiol 274: L721–L727, 1998.Link | ISI | Google Scholar27 Weissmann N, Tadic A, Hanze J, Rose F, Winterhalder S, Nollen M, Schermuly RT, Ghofrani HA, Seeger W, and Grimminger F. Hypoxic vasoconstriction in intact lungs: a role for NADPH oxidase-derived H2O2? Am J Physiol Lung Cell Mol Physiol 279: L683–L690, 2000.Link | ISI | Google Scholar28 Weissmann N, Winterhalder S, Nollen M, Voswinckel R, Quanz K, Ghofrani HA, Schermuly RT, Seeger W, and Grimminger F. NO and reactive oxygen species are involved in biphasic hypoxic vasoconstriction of isolated rabbit lungs. Am J Physiol Lung Cell Mol Physiol 280: L638–L645, 2001.Link | ISI | Google Scholar29 Wolin MS, Ahmad M, and Gupte SA. Oxidant and redox signaling in vascular oxygen sensing mechanisms: basic concepts, current controversies, and potential importance of cytosolic NADPH. Am J Physiol Lung Cell Mol Physiol 289: L159–L173, 2005.Link | ISI | Google Scholar30 Ziel KA, Grishko V, Campbell CC, Breit JF, Wilson GL, and Gillespie MN. Oxidants in signal transduction: impact on DNA integrity and gene expression. FASEB J 19: 387–394, 2005.Crossref | PubMed | ISI | Google Scholar Download PDF Previous Back to Top Next FiguresReferencesRelatedInformationCited ByMitochondrial oxygen sensing of acute hypoxia in specialized cells - Is there a unifying mechanism?Biochimica et Biophysica Acta (BBA) - Bioenergetics, Vol. 1863, No. 8IL-25 Induced ROS-Mediated M2 Macrophage Polarization via AMPK-Associated Mitophagy21 December 2021 | International Journal of Molecular Sciences, Vol. 23, No. 1Acrylamide Induces Mitophagy and Alters Macrophage Phenotype via Reactive Oxygen Species Generation8 February 2021 | International Journal of Molecular Sciences, Vol. 22, No. 4Mitochondria in the Pulmonary Vasculature in Health and Disease: Oxygen‐Sensing, Metabolism, and Dynamics12 March 2020Mitochondrial Dysfunction: Metabolic Drivers of Pulmonary HypertensionAntioxidants & Redox Signaling, Vol. 31, No. 12Ndufs2, a Core Subunit of Mitochondrial Complex I, Is Essential for Acute Oxygen-Sensing and Hypoxic Pulmonary VasoconstrictionCirculation Research, Vol. 124, No. 12Pulmonary effects of remote ischemic preconditioning in a porcine model of ventilation-induced lung injuryRespiratory Physiology & Neurobiology, Vol. 259Oxygen, evolution and redox signalling in the human brain; quantum in the quotidian2 November 2018 | The Journal of Physiology, Vol. 597, No. 1RETRACTED ARTICLE: The quantum physiology of oxygen; from electrons to the evolution of redox signaling in the human brain17 October 2018 | Bioelectronic Medicine, Vol. 4, No. 1Remote Ischemic Preconditioning Decreases Oxidative Lung Damage After Pulmonary LobectomyAnesthesia & Analgesia, Vol. 125, No. 2Hypoxic Pulmonary VasoconstrictionChest, Vol. 151, No. 1Glutathione oxidation correlates with one-lung ventilation time and PO 2 /FiO 2 ratio during pulmonary lobectomy21 January 2016 | Redox Report, Vol. 21, No. 5Molecular mechanisms of hypoxia-inducible factor-induced pulmonary arterial smooth muscle cell alterations in pulmonary hypertension30 September 2015 | The Journal of Physiology, Vol. 594, No. 5Key Role of ROS in the Process of 15-Lipoxygenase/15-Hydroxyeicosatetraenoiccid-Induced Pulmonary Vascular Remodeling in Hypoxia Pulmonary Hypertension12 February 2016 | PLOS ONE, Vol. 11, No. 2A mitochondrial redox oxygen sensor in the pulmonary vasculature and ductus arteriosus23 September 2015 | Pflügers Archiv - European Journal of Physiology, Vol. 468, No. 1Oxygen sensing and signal transduction in hypoxic pulmonary vasoconstriction22 October 2015 | European Respiratory Journal, Vol. 47, No. 1Exaggerated pulmonary vascular response to acute hypoxia in older men14 September 2015 | Experimental Physiology, Vol. 100, No. 10Oxidative lung injury correlates with one-lung ventilation time during pulmonary lobectomy: a study of exhaled breath condensate and blood18 June 2015 | European Journal of Cardio-Thoracic Surgery, Vol. 48, No. 3Emerging Concepts in the Molecular Basis of Pulmonary Arterial HypertensionCirculation, Vol. 131, No. 19The Metabolic Theory of Pulmonary Arterial HypertensionCirculation Research, Vol. 115, No. 1Regulation of Cellular Gas Exchange, Oxygen Sensing, and Metabolic Control1 July 2013Precursors and inhibitors of hydrogen sulfide synthesis affect acute hypoxic pulmonary vasoconstriction in the intact lungJane A. Madden, Susan B. Ahlf, Mark W. Dantuma, Kenneth R. Olson, and David L. Roerig1 February 2012 | Journal of Applied Physiology, Vol. 112, No. 3Hypoxic Pulmonary VasoconstrictionJ. T. Sylvester, Larissa A. Shimoda, Philip I. Aaronson, and Jeremy P. T. Ward1 January 2012 | Physiological Reviews, Vol. 92, No. 1Redox Regulation of Protein Kinases as a Modulator of Vascular FunctionAntioxidants & Redox Signaling, Vol. 15, No. 6Cytochrome P450-Derived Epoxyeicosatrienoic Acids and Pulmonary Hypertension: Central Role of Transient Receptor Potential C6 ChannelsJournal of Cardiovascular Pharmacology, Vol. 57, No. 2Mitochondrial Reactive Oxygen Species and Redox State in Pulmonary Vascular O2 Sensing3 December 2010Distribution of Perfusion1 January 2011Spatial Distribution of Ventilation and Perfusion: Mechanisms and Regulation1 January 2011Redox signaling and reactive oxygen species in hypoxic pulmonary vasoconstrictionRespiratory Physiology & Neurobiology, Vol. 174, No. 3Determinants of Pulmonary Blood Flow Distribution1 November 2010Apparent PKA activity responds to intermittent hypoxia in bone cells: a redox pathway?Yan-Liang Zhang, Hesam Tavakoli, and Mirianas Chachisvilis1 July 2010 | American Journal of Physiology-Heart and Circulatory Physiology, Vol. 299, No. 1Hydrogen Sulfide and Oxygen Sensing in the Cardiovascular SystemAntioxidants & Redox Signaling, Vol. 12, No. 10Vasoactivity of hydrogen sulfide in normoxic and anoxic turtles (Trachemys scripta)Jonathan A. W. Stecyk*, Nini Skovgaard*, Göran E. Nilsson, and Tobias Wang1 May 2010 | American Journal of Physiology-Regulatory, Integrative and Comparative Physiology, Vol. 298, No. 5Hypoxia sensing in the fetal chicken femoral artery is mediated by the mitochondrial electron transport chainBea Zoer, Angel L. Cogolludo, Francisco Perez-Vizcaino, Jo G. R. De Mey, Carlos E. Blanco, and Eduardo Villamor1 April 2010 | American Journal of Physiology-Regulatory, Integrative and Comparative Physiology, Vol. 298, No. 4Hypoxic pulmonary vasodilation: a paradigm shift with a hydrogen sulfide mechanismKenneth R. Olson, Nathan L. Whitfield, Shawn E. Bearden, Judy St. Leger, Erika Nilson, Yan Gao, and Jane A. Madden1 January 2010 | American Journal of Physiology-Regulatory, Integrative and Comparative Physiology, Vol. 298, No. 1The Role of Ion Channels in Hypoxic Pulmonary Vasoconstriction26 December 2009Antioxidant defenses and oxidative stress parameters in tissues of mud crab (Scylla serrata) with reference to changing salinityComparative Biochemistry and Physiology Part C: Toxicology & Pharmacology, Vol. 151, No. 1Endothelial cells and pulmonary arterial hypertension: apoptosis, proliferation, interaction and transdifferentiation13 October 2009 | Respiratory Research, Vol. 10, No. 1Hypoxia Up-regulates CD36 Expression and Function via Hypoxia-inducible Factor-1- and Phosphatidylinositol 3-Kinase-dependent MechanismsJournal of Biological Chemistry, Vol. 284, No. 39Hypoxia-induced oxidative base modifications in the VEGF hypoxia-response element are associated with transcriptionally active nucleosomesFree Radical Biology and Medicine, Vol. 46, No. 3Hydrogen sulfide and oxygen sensing: implications in cardiorespiratory controlJournal of Experimental Biology, Vol. 211, No. 17Hydrogen sulfide as an oxygen sensor in trout gill chemoreceptorsKenneth R. Olson, Michael J. Healy, Zhaohong Qin, Nini Skovgaard, Branka Vulesevic, Douglas W. Duff, Nathan L. Whitfield, Guangdong Yang, Rui Wang, and Steve F. Perry1 August 2008 | American Journal of Physiology-Regulatory, Integrative and Comparative Physiology, Vol. 295, No. 2Generation of Oxidants by Hypoxic Human Pulmonary and Coronary Smooth-Muscle CellsChest, Vol. 133, No. 6Mitochondrial metabolism, redox signaling, and fusion: a mitochondria-ROS-HIF-1α-Kv1.5 O2-sensing pathway at the intersection of pulmonary hypertension and cancerStephen L. Archer, Mardi Gomberg-Maitland, Michael L. Maitland, Stuart Rich, Joe G. N. Garcia, and E. Kenneth Weir1 February 2008 | American Journal of Physiology-Heart and Circulatory Physiology, Vol. 294, No. 2Oxygen sensors in contextBiochimica et Biophysica Acta (BBA) - Bioenergetics, Vol. 1777, No. 1Oxygen sensing in hypoxic pulmonary vasoconstriction: using new tools to answer an age-old question18 December 2007 | Experimental Physiology, Vol. 93, No. 1Hypoxia divergently regulates production of reactive oxygen species in human pulmonary and coronary artery smooth muscle cellsWinnie Wu, Oleksandr Platoshyn, Amy L. Firth, and Jason X.-J. Yuan1 October 2007 | American Journal of Physiology-Lung Cellular and Molecular Physiology, Vol. 293, No. 4Fluvastatin Inhibits Hypoxic Proliferation and p38 MAPK Activity in Pulmonary Artery FibroblastsAmerican Journal of Respiratory Cell and Molecular Biology, Vol. 37, No. 4Role of the plasma membrane ROS-generating NADPH oxidase in CD34+ progenitor cells preservation by hypoxiaJournal of Biotechnology, Vol. 130, No. 4Point: Release of an endothelium-derived vasoconstrictor and RhoA/Rho kinase-mediated calcium sensitization of smooth muscle cell contraction are/are not the main effectors for full and sustained hypoxic pulmonary vasoconstrictionTom P. Robertson1 May 2007 | Journal of Applied Physiology, Vol. 102, No. 5Role of Reactive Oxygen Species in Chronic Hypoxia-Induced Pulmonary Hypertension and Vascular RemodelingThe cellular basis for diverse responses to oxygenFree Radical Biology and Medicine, Vol. 42, No. 2Hypoxic pulmonary vasoconstriction is/is not mediated by increased production of reactive oxygen speciesPhilip I. Aaronson1 September 2006 | Journal of Applied Physiology, Vol. 101, No. 3Last Word: Point:Counterpoint authors respond to commentaries on “Hypoxic pulmonary vasoconstriction is/is not mediated by increased production of reactive oxygen species”Jeremy P. T. Ward1 September 2006 | Journal of Applied Physiology, Vol. 101, No. 3 More from this issue > Volume 101Issue 3September 2006Pages 993-995 Copyright & PermissionsCopyright © 2006 the American Physiological Societyhttps://doi.org/10.1152/japplphysiol.00480.2006PubMed16675614History Published online 1 September 2006 Published in print 1 September 2006 Metrics